Document is current
Any future updates will be listed below
-
Authors
Klein, Benjamin
Nguyen, Nguyen Thi Kim
Moallemian, Rezvan
Kahlenberg, J. Michelle
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR071384, R01AR081640, K24AR076975)
Deutsche Forschungsgemeinschaft (KL3612-1/1)
Alliance for Lupus Research (LTMA)
Rheumatology Research Foundation (Innovative Research Award)
- License Information
-
More Information
Article History
Accepted: 22 October 2024
First Online: 21 November 2024
Declarations
:
: Dr. Kahlenberg reports grant funding from Bristol Myers Squibb (BMS, Janssen, Ventus Therapeutics, and Rome Therapeutics. Dr. Kahlenberg has received fees for consulting for AstraZeneca, Biogen, BMS, Eli Lilly, Ventus Therapeutics, GlaxoSmithKlein, Lupus Therapeutics, Rome Therapeutics, Related Science LLC, Exo Therapeutics, and Vividion. All other authors have nothing to declare.
